Epidemiology and Outcomes of Extrapulmonary Invasive Fungal Infections After Kidney Transplantation in Northern India
- 14 May 2026
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (4) , e70218
Abstract
Background: Extrapulmonary invasive fungal infections (IFIs) in kidney transplant recipients (KTRs) are understudied, particularly in endemic, resource‐limited settings. This study evaluated the epidemiology, risk factors, and outcomes of extrapulmonary IFIs in KTRs in northern India. Methods: In this nested case‐control study of 1649 KTRs (2007–2022), microbiologically proven extrapulmonary IFI cases were identified from microbiology and histopathology databases. Results: Extrapulmonary IFI occurred in 67 KTRs (4.1%). Cryptococcosis (46.3%) and candidiasis (20.9%) were the predominant infections. The central nervous system was the most common site (44.8%), followed by the bloodstream (22.4%). The mean age was 46.78 years, and 85.1% were males. The median time to infection was 55 months posttransplant, and 79.1% of infections occurred beyond 1 year posttransplant. Median estimated glomerular filtration rate (eGFR) was 43 mL/min/1.73 m 2 , and acute graft dysfunction was present in 49.3% cases. Comorbidities included diabetes (44.8%), chronic renal allograft injury (59.7%), acute rejection (38.8%), bacterial infection (26.9%), and cytomegalovirus disease (13.4%). Diabetes (OR 2.27, p = 0.038) and methylprednisolone pulses for rejection (OR 3.19, p = 0.025) were independently associated with IFI. Infection‐related mortality was 35.8%; disseminated infection (HR 3.72, p = 0.020) and requirement for kidney replacement therapy (KRT) (HR 3.98, p = 0.011) independently predicted death. Note that, 5‐ and 10‐year patient survival was significantly lower in cases than in controls (74.1% and 48.3% vs. 92.3% and 74.9%; p = 0.008), whereas death‐censored graft survival was comparable. Conclusions: Extrapulmonary IFIs are late‐onset and commonly present as cryptococcal meningitis or candidemia. Diabetes and methylprednisolone pulses increase infection risk, while dissemination and KRT requirement predict mortality. imageKeywords
This publication has 35 references indexed in Scilit:
- The epidemiology of invasive fungal infections in transplant recipientsBiomedical Journal, 2024
- Fungal infections: Pathogenesis, antifungals and alternate treatment approachesCurrent Research in Microbial Sciences, 2022
- Fungal lung diseasePaediatric Respiratory Reviews, 2021
- Risk Factors Associated With Invasive Fungal Infections in Kidney Transplant PatientsThe American Journal of the Medical Sciences, 2020
- Invasive candidiasisNature Reviews Disease Primers, 2018
- EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipientsRevista Iberoamericana de Micologia, 2016
- Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practiceCurrent Opinion in Pharmacology, 2015
- Infectious Complications of Antilymphocyte Therapies in Solid Organ TransplantationClinical Infectious Diseases, 2009
- Antifungal agents for preventing fungal infections in solid organ transplant recipientsCochrane Database of Systematic Reviews, 2004
- Overview: pathogenesis of fungal infections in the organ transplant recipientTransplant Infectious Disease, 2002